Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease
Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease
复制标题
DOI:
10.1378/chest.113.5.1250
复制
发表时间:
1998-05-01
期刊:
影响因子:
9.6
通讯作者:
Presberg, KW
中科院分区:
文献类型:
--
作者:
Tan, RT;Kuzo, R;Presberg, KW
Objective: To determine the utility of CT-determined main pulmonary artery diameter (MPAD) for predicting pulmonary hypertension (PH) in patients with parenchymal lung disease.Design: Retrospective review of right-heart hemodynamic data and chest CT scans in 45 patients.Setting: Tertiary-referral teaching hospital and VA hospital.Patients: Between October 1990 and December 1995, 36 patients referred for evaluation of parenchymal lung disease or possible pulmonary vascular disease were found to have PH, as defined by mean pulmonary artery pressure (mPAP) greater than or equal to 20 mm Hg. Nine control patients (mPAP 1:1 in three or four lobes (specificity, 100%). There was no linear correlation between the degree of PH and MPAD (r=0.124).Conclusions: CT-determined MPAD has excellent diagnostic value for detection of PR in patients with advanced lung disease. Therefore, standard chest CT scans can be used to screen for PH as a cause of exertional limitation in patients with parenchymal lung disease. Because CT is commonly used to evaluate parenchymal lung disease, this information is readily available.